A Phase 1b Study of STMC-103H in Multi-Sensitized Allergic Subjects Who Are Otherwise Healthy

NCT03819881 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Immunoglobulin E-Mediated Allergic Disorder

Interventions

BIOLOGICAL: STMC-103H
BIOLOGICAL: Placebo

Sponsor

Siolta Therapeutics, Inc.

Collaborators

[object Object]